AzTrials
AzTrials

PainNCT05627869

Effects of TTPB vs PIFB on Opioid Consumption in Patients After Cardiac Surgery.

A study testing Transversus thoracic plane block and Pecto intercostal fascial block in people with Pain and Postoperative, run by Beni-Suef University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of this study is to compare the effects of TTPB vs PIFB on postoperative opioid consumption in patients undergoing open cardiac surgery. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Pain, Postoperative
What is being tested?
Transversus thoracic plane block and Pecto intercostal fascial block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteEgypt
Study dates
1 Feb 2023to Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 18 and 75 years.
  • Patient scheduled to undergo elective on-pump cardiac surgery with sternotomy.
  • American Society of Anesthesiologists classification of physical status < IV.

Who cannot join

  • Emergency surgery.
  • Off-pump surgery.
  • Redo surgery.
  • Ejection fraction less than 35%.
  • Refusal of the patient.
  • Known hypersensitivity to LA.
Show all 13Show fewer
  • Chronic opioid use or chronic pain patient.
  • Psychiatric problems or communication difficulties.
  • Liver insufficiency (defined as a serum bilirubin ≥ 34 μmol/l, albumin ≤ 35 g/dl, INR ≥ 1.7)
  • Renal insufficiency (defined as a glomerular filtration rate < 44 ml/min).
  • Obstructive sleep apnea syndrome.
  • Coexisting hematologic disorders.
  • Pregnancy or breastfeeding.

Trial locations and contacts

1 site in 1 country.

Mariana A Mansour, lecturer contact

01222960009

mrmrsyk4@gmail.com

Egypt1 site, 1 recruiting
  • Benisuef University Hospital

    Benisuef

    مريانة عبد السيد سليمان, MD, 01222960009, mrmrsyk4@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Comparison of Effects of Transversus Thoracic Muscle Plane Block vs Pecto-intercostal Fascial Block on Postoperative Opioid Consumption in Patients Undergoing Open Cardiac Surgery: A Prospective Randomized Study

The objective of this study is to compare the effects of TTPB vs PIFB on postoperative opioid consumption in patients undergoing open cardiac surgery.

Read the detailed description

Cardiac surgery performed through median sternotomy is associated with significant postoperative pain.Poststernotomy pain leads to decreased patient satisfaction, delirium, cardiovascular complications (hypertension, tachycardia, arrhythmias), hyperglycemia and respiratory complications (bronchial secretion stasis, atelectasis and pneumonia).High-dose opioids can provide good postoperative analgesia for patients undergoing heart surgery. However, opioids have some side effects.The advent of ultrasound-guided regional anaesthesia led to the development of fascial plane chest wall block as transthoracic plane block and pectointercostal fascial block.

Conditions
Pain, Postoperative
Being tested
Transversus thoracic plane block, Pecto intercostal fascial block
Keywords
TTPB, PIFB
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transversus thoracic plane blockProcedure or surgery

    Also called sunnypivacaine

    TTPB group will receive bilateral ultrasound-guided transversus thoracic muscle plane block using 20 ml of bupivacaine 0.25% for each side.

  • Pecto intercostal fascial blockProcedure or surgery

    Also called sunnypivacaine

    PIFB group will receive bilateral ultrasound-guided Pecto-intercostal fascial plane block using 20 ml of bupivacaine 0.25% for each side.

Study groups in NCT05627869
Study groupRoleWhat they receive
Transversus thoracic muscle plane blockActive comparatorTTPB group will receive bilateral ultrasound-guided transversus thoracic muscle plane block using 20 ml of bupivacaine 0.25% for each side.
Receives: Procedure: Transversus thoracic plane block
Pecto-intercostal fascial plane blockActive comparatorPIFB group will receive bilateral ultrasound-guided Pecto-intercostal fascial plane block using 20 ml of bupivacaine 0.25% for each side.
Receives: Procedure: Pecto intercostal fascial block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary outcome will be total morphine consumption

    Total morphine consumption within 24 hours according Visual Analogue Score (VAS) for sternal pain both during rest and with cough (ranging from 0 indicating no pain to 10 indicating extreme pain). A score ≤ 3 was considered acceptable for pain relief. Supplementary rescue analgesia was administered in the form of morphine IV 0.05 mg/kg (at VAS ≥ 4).

    Measured: 24 hours

Secondary outcomes (1)
  1. The secondary outcomes will be the first analgesic request time

    Is the time to ask for the first postoperative analgesia (morphine), and will be calculated from extubation to patient reporting Visual Analogue Score (VAS) ≥ 4.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Nov 2022
  2. Study start1 Feb 2023
  3. Primary completionJul 2023 (estimated)
  4. Study completionJul 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05627869
Sponsor's protocol ID
Mariana AbdElsayed
Status last verified
Jul 2023
First submitted
1 Nov 2022
Last updated
11 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: TITLE

Publications

  • Mansour MA, Mahmoud HE, Fakhry DM, Kassim DY. Comparison of the effects of transversus thoracic muscle plane block and pecto-intercostal fascial block on postoperative opioid consumption in patients undergoing open cardiac surgery: a prospective randomized study. BMC Anesthesiol. 2024 Feb 10;24(1):63. doi: 10.1186/s12871-024-02432-w.

    PubMed 38341525

Questions about this trial

What is this clinical trial studying?

A study testing Transversus thoracic plane block and Pecto intercostal fascial block in people with Pain and Postoperative, run by Beni-Suef University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mariana A Mansour, lecturer (01222960009, mrmrsyk4@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary outcome will be total morphine consumption (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05627869, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in